NASTAD

📣 Registration is now open for TRANSPIRE 2026!

TRANSPIRE is NASTAD's national technical assistance conference for state, local, and territorial health departments — and this year's event is shaping up to be our most dynamic yet.

📅 September 28 – October 1, 2026
📍 Scottsdale, AZ

This year's conference will bring together 300+ public health professionals. Attendees can expect a rich mix of plenaries, 90-minute workshops, and 3-hour implementation sandboxes designed to build real skills and tackle emerging challenges.

Conference tracks include:
🔹 Rural Health Strategies
🔹 Evolving Public Health Landscape
🔹 Meaningful Partnerships
🔹 Data & Storytelling

Register today → nastad.org/TRANSPIRE/Registration and view the agenda here https://nastad.org/TRANSPIRE/Agenda

💛 Hepatitis C is curable — and a new CDC study shows that treating it could save our healthcare system $147 billion.

A study just published in the journal BMC Health Services Research found that curative treatment for hepatitis C saves an average of $65,841 per person in lifetime medical costs. Multiply that across the more than 2 million Americans living with the virus, and the potential savings are enormous — and that's before factoring in costs like lost work, caregiving, and quality of life.

The treatment is a once-daily oral medication taken for just 8 to 12 weeks, with a cure rate above 95%.

So why are we still losing more than 10,000 people a year to hepatitis C?
Because millions of people don't know they have it. Hepatitis C often causes no symptoms for years — silently damaging the liver until it's much harder to treat.
The first step is simple: get tested.

The CDC recommends that all adults 18 and older be screened for hepatitis C at least once in their lifetime. If you haven't been screened, talk to your doctor. If you know someone who hasn't — share this post.

🧡Check out this article from the CDC to learn more. https://www.cdc.gov/nchhstp/whats-new/hepatitis-c-treatment-saves.html